These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33516794)

  • 21. Spheronization of small extrudates containing kappa-carrageenan.
    Yoo A; Kleinebudde P
    J Pharm Sci; 2009 Oct; 98(10):3776-87. PubMed ID: 19130471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of 400 microm pellets by extrusion-spheronization: application with Gelucire 50/02 to produce a "sprinkle" form.
    Flament MP; Dupont G; Leterme P; Farah N; Gayot A
    Drug Dev Ind Pharm; 2004 Jan; 30(1):43-51. PubMed ID: 15000429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manufacture of fine spherical granules by an extrusion/spheronization method.
    Kanbe H; Hayashi T; Onuki Y; Sonobe T
    Int J Pharm; 2007 Jun; 337(1-2):56-62. PubMed ID: 17257789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations.
    Barbosa EJ; Ferraz HG
    Acta Pharm; 2019 Mar; 69(1):99-109. PubMed ID: 31259713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protocol for the classification of wet mass in extrusion-spheronization.
    Gao Y; Hong Y; Xian J; Lin X; Shen L; Zhang X; Zhang N; Feng Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):996-1005. PubMed ID: 23563104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J; Rabisková M
    Int J Pharm; 2002 Aug; 242(1-2):349-51. PubMed ID: 12176277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of spray nozzle aperture during high shear wet granulation on granule properties and its compression attributes.
    Veronica N; Goh HP; Kang CYX; Liew CV; Heng PWS
    Int J Pharm; 2018 Dec; 553(1-2):474-482. PubMed ID: 30385375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of Stokes deformation number as a predictive tool for material exchange behaviour of granules in the 'equilibrium phase' in high shear granulation.
    Bouwman AM; Visser MR; Meesters GM; Frijlink HW
    Int J Pharm; 2006 Aug; 318(1-2):78-85. PubMed ID: 16713144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y; Shi CY; Fang JG; Wang WQ
    Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
    Sarkar S; Heng PW; Liew CV
    Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time image-based investigation of spheronization and drying phenomena using different pellet formulations.
    Burggraeve A; Sandler N; Heinämäki J; Räikkönen H; Remon JP; Vervaet C; De Beer T; Yliruusi J
    Eur J Pharm Sci; 2011 Dec; 44(5):635-42. PubMed ID: 22033152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of plate design on the properties of pellets produced by extrusion and spheronization.
    Michie H; Podczeck F; Newton JM
    Int J Pharm; 2012 Sep; 434(1-2):175-82. PubMed ID: 22659150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of chitosan pellets by extrusion/spheronization.
    Steckel H; Mindermann-Nogly F
    Eur J Pharm Biopharm; 2004 Jan; 57(1):107-14. PubMed ID: 14729086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
    Krueger C; Thommes M
    Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR; Agrawal MK; Kumria R
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.